vs

Side-by-side financial comparison of Star Equity Holdings, Inc. (STRR) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.

Vanda Pharmaceuticals Inc. is the larger business by last-quarter revenue ($57.2M vs $56.8M, roughly 1.0× Star Equity Holdings, Inc.). Star Equity Holdings, Inc. runs the higher net margin — -3.0% vs -246.8%, a 243.8% gap on every dollar of revenue. On growth, Star Equity Holdings, Inc. posted the faster year-over-year revenue change (69.0% vs 7.6%). Star Equity Holdings, Inc. produced more free cash flow last quarter ($-9.0M vs $-29.5M). Over the past eight quarters, Star Equity Holdings, Inc.'s revenue compounded faster (29.5% CAGR vs 9.8%).

Artists Equity is an American production company founded by actors and filmmakers Ben Affleck and Matt Damon in November 2022.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.

STRR vs VNDA — Head-to-Head

Bigger by revenue
VNDA
VNDA
1.0× larger
VNDA
$57.2M
$56.8M
STRR
Growing faster (revenue YoY)
STRR
STRR
+61.4% gap
STRR
69.0%
7.6%
VNDA
Higher net margin
STRR
STRR
243.8% more per $
STRR
-3.0%
-246.8%
VNDA
More free cash flow
STRR
STRR
$20.6M more FCF
STRR
$-9.0M
$-29.5M
VNDA
Faster 2-yr revenue CAGR
STRR
STRR
Annualised
STRR
29.5%
9.8%
VNDA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
STRR
STRR
VNDA
VNDA
Revenue
$56.8M
$57.2M
Net Profit
$-1.7M
$-141.2M
Gross Margin
Operating Margin
-0.2%
-70.5%
Net Margin
-3.0%
-246.8%
Revenue YoY
69.0%
7.6%
Net Profit YoY
-192.1%
-2774.3%
EPS (diluted)
$-0.49
$-2.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STRR
STRR
VNDA
VNDA
Q4 25
$56.8M
$57.2M
Q3 25
$48.0M
$56.3M
Q2 25
$35.5M
$52.6M
Q1 25
$31.9M
$50.0M
Q4 24
$33.6M
$53.2M
Q3 24
$36.9M
$47.7M
Q2 24
$35.7M
$50.5M
Q1 24
$33.9M
$47.5M
Net Profit
STRR
STRR
VNDA
VNDA
Q4 25
$-1.7M
$-141.2M
Q3 25
$-1.8M
$-22.6M
Q2 25
$-688.0K
$-27.2M
Q1 25
$-1.8M
$-29.5M
Q4 24
$-585.0K
$-4.9M
Q3 24
$-846.0K
$-5.3M
Q2 24
$-441.0K
$-4.5M
Q1 24
$-2.9M
$-4.1M
Gross Margin
STRR
STRR
VNDA
VNDA
Q4 25
Q3 25
43.0%
Q2 25
Q1 25
Q4 24
Q3 24
50.5%
Q2 24
Q1 24
Operating Margin
STRR
STRR
VNDA
VNDA
Q4 25
-0.2%
-70.5%
Q3 25
-3.4%
-55.6%
Q2 25
-0.6%
-73.2%
Q1 25
-5.4%
-82.0%
Q4 24
-0.4%
-19.3%
Q3 24
-1.2%
-23.1%
Q2 24
-0.5%
-20.1%
Q1 24
-9.0%
-19.5%
Net Margin
STRR
STRR
VNDA
VNDA
Q4 25
-3.0%
-246.8%
Q3 25
-3.7%
-40.1%
Q2 25
-1.9%
-51.7%
Q1 25
-5.5%
-58.9%
Q4 24
-1.7%
-9.2%
Q3 24
-2.3%
-11.2%
Q2 24
-1.2%
-9.0%
Q1 24
-8.6%
-8.7%
EPS (diluted)
STRR
STRR
VNDA
VNDA
Q4 25
$-0.49
$-2.40
Q3 25
$-0.54
$-0.38
Q2 25
$-0.23
$-0.46
Q1 25
$-0.59
$-0.50
Q4 24
$-0.21
$-0.09
Q3 24
$-0.28
$-0.09
Q2 24
$-0.15
$-0.08
Q1 24
$-0.95
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STRR
STRR
VNDA
VNDA
Cash + ST InvestmentsLiquidity on hand
$10.3M
$84.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$65.7M
$327.2M
Total Assets
$113.2M
$488.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STRR
STRR
VNDA
VNDA
Q4 25
$10.3M
$84.9M
Q3 25
$15.4M
$70.0M
Q2 25
$16.8M
$81.0M
Q1 25
$16.6M
$111.8M
Q4 24
$17.0M
$102.3M
Q3 24
$15.8M
$100.5M
Q2 24
$14.7M
$103.0M
Q1 24
$20.4M
$125.2M
Total Debt
STRR
STRR
VNDA
VNDA
Q4 25
Q3 25
$6.5M
Q2 25
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
STRR
STRR
VNDA
VNDA
Q4 25
$65.7M
$327.2M
Q3 25
$67.8M
$466.0M
Q2 25
$40.1M
$486.3M
Q1 25
$39.5M
$511.4M
Q4 24
$40.4M
$538.5M
Q3 24
$42.9M
$541.2M
Q2 24
$42.6M
$542.5M
Q1 24
$44.3M
$544.0M
Total Assets
STRR
STRR
VNDA
VNDA
Q4 25
$113.2M
$488.9M
Q3 25
$117.1M
$601.1M
Q2 25
$55.6M
$624.7M
Q1 25
$53.2M
$631.9M
Q4 24
$52.6M
$656.2M
Q3 24
$52.6M
$645.1M
Q2 24
$52.6M
$651.4M
Q1 24
$52.6M
$652.7M
Debt / Equity
STRR
STRR
VNDA
VNDA
Q4 25
Q3 25
0.10×
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STRR
STRR
VNDA
VNDA
Operating Cash FlowLast quarter
$-7.3M
$-29.4M
Free Cash FlowOCF − Capex
$-9.0M
$-29.5M
FCF MarginFCF / Revenue
-15.8%
-51.6%
Capex IntensityCapex / Revenue
3.0%
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-13.0M
$-110.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STRR
STRR
VNDA
VNDA
Q4 25
$-7.3M
$-29.4M
Q3 25
$-2.7M
$-31.6M
Q2 25
$139.0K
$-15.3M
Q1 25
$-802.0K
$-33.1M
Q4 24
$-2.8M
$-1.8M
Q3 24
$1.3M
$-14.6M
Q2 24
$-4.3M
$-6.9M
Q1 24
$-1.8M
$7.6M
Free Cash Flow
STRR
STRR
VNDA
VNDA
Q4 25
$-9.0M
$-29.5M
Q3 25
$-3.4M
$-31.8M
Q2 25
$102.0K
$-15.6M
Q1 25
$-808.0K
$-33.6M
Q4 24
$-2.8M
$-2.0M
Q3 24
$1.3M
$-14.7M
Q2 24
$-4.3M
$-7.0M
Q1 24
$-1.8M
$7.6M
FCF Margin
STRR
STRR
VNDA
VNDA
Q4 25
-15.8%
-51.6%
Q3 25
-7.0%
-56.5%
Q2 25
0.3%
-29.6%
Q1 25
-2.5%
-67.1%
Q4 24
-8.3%
-3.8%
Q3 24
3.4%
-30.9%
Q2 24
-12.0%
-13.9%
Q1 24
-5.3%
15.9%
Capex Intensity
STRR
STRR
VNDA
VNDA
Q4 25
3.0%
0.2%
Q3 25
1.3%
0.3%
Q2 25
0.1%
0.6%
Q1 25
0.0%
0.9%
Q4 24
0.1%
0.4%
Q3 24
0.0%
0.3%
Q2 24
0.0%
0.2%
Q1 24
0.0%
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

STRR
STRR

Revenue From Other Contracts With Customers$27.6M49%
Other$24.3M43%
Energy Services Segment$4.9M9%

VNDA
VNDA

Fanapt$33.2M58%
Hetlioz$16.4M29%
PONVORY$7.6M13%

Related Comparisons